Dietary indiscretion and statin use.
To determine whether statin use leads to dietary indiscretion, this longitudinal cohort study examined the impact of statin initiation on saturated fat intake. We interviewed 71 patients who had received a new prescription for statins for primary prevention of cardiovascular disease, first at the time of prescription and then again 3 and 6 months later. Patients were asked about their beliefs regarding diet and medications as well as their diet during the past 24 hours in all interviews and about their adherence to statins in the 3- and 6-month follow-up interviews. At the time of statin prescription, 54 participants (76 percent) wanted to reduce dietary fat, 50 (70 percent) believed statin use could cure their hyperlipidemia, and 31 (44 percent) thought that physicians prescribed statins to them despite their preference to continue to try dietary changes. After 6 months of statin use, no significant change in saturated fat intake was noted.
Division of General Internal Medicine, Mount Sinai School of Medicine, 1470 Madison Avenue, Box 1087, New York, NY 10029, USA. devin.mann@mountsinai.org
Devin M
DM
Mann
John P
JP
Allegrante
Sundar
S
Natarajan
Victor M
VM
Montori
Ethan A
EA
Halm
Mary
M
Charlson
D001294:Attitude to Health; D002318:Cardiovascular Diseases / Q000517:prevention & control; D015331:Cohort Studies; D003863:Depression / Q000150:complications; D018752:Diet, Fat-Restricted; D004041:Dietary Fats / Q000008:administration & dosage*; D005247:Feeding Behavior / Q000523:psychology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000178:diet therapy / Q000188:drug therapy; D006973:Hypertension / Q000150:complications; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009042:Motivation; D050177:Overweight; D010349:Patient Compliance; D011322:Primary Prevention; D012907:Smoking
D004041:Dietary Fats; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors